I think those that had to sell are likely done or are willing to wait it out.
Book Value is $8 and is a better approximation of where this ought to be.
The reason that shares traded at $13 - 15 was because of the dividend.
If shares traded at $8 before the dividend cut, the yield would have been 14.375% which is extremely high.
At $13.50 (where the stock traded for a large part of 2012) the yield was 8.52%
That was still a high yield, but it did not go lower because there was some sense of reality in the valuation (ie. it didn't trade 2 to 3 times book value).
The dividend cut was a necessary evil as it is next to impossible to maintain a 100% payout ratio, especially when your assets have a limited life and investment in new purchases is a fact of a continuing business.
As a potential investment, the stock's current valuation is low and there appears to be a lot of room for appreciation.
I think a number of people are waiting and watching for the stock to bottom out.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM